Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Immunothrombosis—immune-mediated activation of coagulation—is protective against
pathogens, but excessive immunothrombosis can result in pathological thrombosis and …

Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …

BACKGROUND: Thrombo-inflammation is central to COVID-19-associated coagulopathy. TF
(tissue factor), a driver of disordered coagulation and inflammation in viral infections, may be …

Please see the Editorial Comment by Andetta Hunsaker discussing this article. Filling
defects identified in the pulmonary arterial tree are commonly presumed to represent an …

Over three years have passed since the COVID-19 pandemic started. The dangerousness
and impact of COVID-19 should definitely not be ignored or underestimated. Other than the …

Abstract Coronavirus Disease 2019 (COVID-19) has been linked to severe consequences
among hospitalized patients diagnosed with pulmonary hypertension (PH), as evidenced by …

Purpose Extracorporeal membrane oxygenation (ECMO) is employed to support critically ill
COVD-19 patients. The occurrence of ischemic stroke and intracranial hemorrhage (ICH), as …

Background COVID-19 causes consequences such as imbalance of the immune system and
thrombotic events. During the infection process, NETs in excess induce a pro-inflammatory …

Recent publications have questioned the efficacy of using therapeutic or intermediate doses
of low molecular weight heparin in COVID-19 patients, especially in the most severe …